CWGCX
Price
$76.26
Change
+$0.53 (+0.70%)
Updated
Dec 3 closing price
Net Assets
142.32B
JORAX
Price
$21.41
Change
+$0.02 (+0.09%)
Updated
Dec 3 closing price
Net Assets
3.12B
Interact to see
Advertisement

CWGCX vs JORAX

Header iconCWGCX vs JORAX Comparison
Open Charts CWGCX vs JORAXBanner chart's image
American Funds Capital World Gr&Inc C
Price$76.26
Change+$0.53 (+0.70%)
VolumeN/A
Net Assets142.32B
Janus Henderson Global Select A
Price$21.41
Change+$0.02 (+0.09%)
VolumeN/A
Net Assets3.12B
CWGCX vs JORAX Comparison Chart in %
View a ticker or compare two or three
VS
CWGCX vs. JORAX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CWGCX is a StrongBuy and JORAX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CWGCX has more cash in the bank: 142B vs. JORAX (3.12B). JORAX (0.76) and CWGCX (0.75) have matching dividends . CWGCX was incepted earlier than JORAX: CWGCX (25 years) vs JORAX (16 years). CWGCX (1.49) is less costly to investors than JORAX (1.02). JORAX is a more actively managed with annual turnover of: 36.00 vs. CWGCX (27.00). CWGCX has a lower initial minimum investment than JORAX: CWGCX (250) vs JORAX (2500). CWGCX annual gain was more profitable for investors over the last year : 12.16 vs. JORAX (3.75). CWGCX return over 5 years is better than : 37.45 vs. JORAX (23.70).
CWGCXJORAXCWGCX / JORAX
Total Expense Ratio1.491.02146%
Annual Report Gross Expense Ratio1.491.02146%
Fund Existence25 years16 years-
Gain YTD22.21518.222122%
Front LoadN/A6%-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets142B3.12B4,545%
Annual Yield % from dividends0.750.7698%
Returns for 1 year12.163.75324%
Returns for 3 years47.6130.22158%
Returns for 5 years37.4523.70158%
Returns for 10 years76.1374.38102%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FBTCX30.220.71
+2.41%
Fidelity Advisor Biotechnology C
AIHHX7.370.08
+1.10%
Aristotle Small/Mid Cap Equity I-2
BAFWX57.520.29
+0.51%
Brown Advisory Sustainable Growth I
CAPAX9.350.04
+0.43%
Federated Hermes Capital Income A
SCRUX12.130.02
+0.17%
Invesco Income Advantage U.S. Fund R